Hematology & Oncology Doctors in Champaign, IL Accepting Medicare

4 Hematology & Oncology doctors found. Showing 1 - 4

Dr. Mohammed Eikram, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 101 W University Ave, Champaign, IL 61820 Phone: 217-366-1299

Kathleen Marie Naegele, D.O. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 W University Ave, Champaign, IL 61820 Phone: 217-366-1299

Dr. Krishnan Srinivasan, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 W University Ave, Champaign, IL 61820 Phone: 217-366-1299

Shrunjal Manish Shah, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 W University Ave, Champaign, IL 61820 Phone: 217-366-1299

News Archive

Wyss Institute scientists develop better assay for testing hemostasis

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function.

Ambulatory monitoring will become more and more part of patients' everyday lives

In the future, patients will become even more involved in the observation and monitoring of their own health or illnesses. For example, blood pressure can be checked 24 hours a day using a blood pressure cuff at home.

Religious people more prone to obesity: Study explores link

A new study has shown that people who frequently attend religious services are significantly more likely to become obese by the time they reach middle age. The finding is surprising especially considering that religious people tend to be in better health than others, said study author Matthew J. Feinstein, a medical student at Northwestern University in Chicago. Feinstein said, "It highlights a particular group that appears to be at a greater risk of becoming obese and remaining obese…It's a group that may benefit from targeted anti-obesity interventions and from obesity prevention programs."

Achievement of tenth milestone triggers EUR 2.5 million payment from Boehringer Ingelheim to Evotec

Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone, triggering a payment of EUR 2.5 million to Evotec. The milestone reached was the selection of a candidate compound for pre-development studies in an inflammation and immunology programme.

MacroChem acquires Virium Pharmaceuticals

MacroChem Corporation announced today that on April 18, 2008 it acquired Virium Pharmaceuticals Inc., a non-public, development stage company developing and commercializing novel therapeutics, with a portfolio of clinical stage product candidates focused in oncology, including its next generation nucleoside analogue licensed from the Southern Research Institute.

Read more Medical News

› Verified 2 days ago